BONJELA

This brand name is authorized in Hong Kong, Ireland, Malta, Singapore, United Kingdom, South Africa

Active ingredients

The drug BONJELA contains a combination of these active pharmaceutical ingredients (APIs):

1 Choline salicylate UNII KD510K1IQW - CHOLINE SALICYLATE

Choline salicylate is an anti-inflammatory and antipyretic medication. It is often used in oral gel form for the relief of pain, discomfort, and inflammation caused by common mouth ulcers, cold sores, denture and sore spots, as well as mouth ulcers, and sore spots because of orthodontic devices. Read about Choline salicylate

2 Alkyldimethylbenzylammonium chloride UNII 85474O1N9D - CETALKONIUM CHLORIDE

Read about Alkyldimethylbenzylammonium chloride

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BONJELA Gel	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A01AD11	Various	A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AD Other agents for local oral treatment
Discover more medicines within A01AD11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 26797
Country: HK	Department of Health Drug Office	Identifier(s): 37437
Country: MT	Medicines Authority	Identifier(s): MA096/00801
Country: SG	Health Sciences Authority	Identifier(s): 04303P
Country: ZA	Health Products Regulatory Authority	Identifier(s): S/16.4/372